Merck KGaA Credit Rating

Results 1 - 50 Of 84

Page Of 2 Next

Filter By:

Date	Document Type	Title	Source
14 Dec 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
23 Nov 2023	Credit Opinion	Merck KGaA: Update to credit analysis	Moody's Investors Service
21 Jun 2023	Issuer Profile	Merck KGaA: Key facts and statistics - Q1 March 2023	Moody's Investors Service
27 Mar 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
26 Oct 2022	Credit Opinion	Merck KGaA: Update to credit analysis	Moody's Investors Service
19 Apr 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
22 Oct 2021	Credit Opinion	Merck KGaA: Update following upgrade to A3	Moody's Investors Service
21 Oct 2021	Rating Action	Moody's upgrades Merck KGaA's rating to A3; stable outlook	Moody's Investors Service
02 Jul 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck KGaA	Moody's Investors Service
29 Apr 2021	Credit Opinion	Merck KGaA: Update to credit analysis	Moody's Investors Service
11 Aug 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck KGaA	Moody's Investors Service
27 Apr 2020	Credit Opinion	Merck KGaA: Update following publication of 2019 results	Moody's Investors Service
17 Jan 2020	Issuer Profile	Merck KGaA: Key Facts and Statistics - LTM September 2019	Moody's Investors Service
24 Sep 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck KGaA	Moody's Investors Service
18 Jun 2019	Announcement	Moody's: Versum shareholders approve acquisition by Merck KGaA	Moody's Investors Service
18 Apr 2019	Credit Opinion	Merck KGaA: Update following rating affirmation	Moody's Investors Service
16 Apr 2019	Rating Action	Moody's affirms Merck KGaA's ratings; stable outlook	Moody's Investors Service
27 Feb 2019	Issuer Comment	Merck KGaA: Combination with Versum would strengthen business profile, but would increase leverage	Moody's Investors Service
17 Jul 2018	Credit Opinion	Merck KGaA: Update following rating affirmation	Moody's Investors Service
13 Jul 2018	Rating Action	Moody's affirms Merck KGaA's Baa1 ratings	Moody's Investors Service
20 Apr 2018	Issuer Comment	Merck KGaA: Merck KGaA’s disposal of consumer health business is credit positive	Moody's Investors Service
11 Jul 2017	Credit Opinion	Merck KGaA: Update to discussion of key credit factors	Moody's Investors Service
23 May 2017	Issuer Profile	Merck KGaA: Key Facts and Statistics – FYE December 2016	Moody's Investors Service
25 Apr 2017	Issuer Comment	Merck KGaA: Merck’s divestment of biosimilar division is credit positive	Moody's Investors Service
01 Sep 2016	Credit Opinion	Merck KGaA: Credit Opinion Update	Moody's Investors Service
30 Aug 2016	Rating Action	Moody's changes outlook on Merck KGaA's ratings to stable from negative; affirms ratings	Moody's Investors Service
27 Jun 2016	Company Profile	Merck KGaA	Moody's Investors Service
08 Mar 2016	Issuer Comment	Merck KGaA: 2015 results in line with expectations, strong commitment to deleveraging supports current rating	Moody's Investors Service
15 Dec 2015	Credit Opinion	Merck KGaA	Moody's Investors Service
10 Aug 2015	Issuer Comment	Pharmaceuticals - EMEA: Merck KGaA: H1 2015 results in line with expectation, full year 2015 outlook confirmed	Moody's Investors Service
07 Aug 2015	Company Profile	Merck KGaA	Moody's Investors Service
21 Jul 2015	Issuer Comment	Merck KGaA: Peer Snapshot	Moody's Investors Service
01 Jul 2015	Issuer Comment	EMEA Pharmaceuticals: Positive top line results for ocrelizumab is credit positive for Roche but credit negative for Merck KGaA	Moody's Investors Service
16 Apr 2015	Issuer Comment	Merck KGaA: Peer Snapshot	Moody's Investors Service
05 Mar 2015	Issuer Comment	EMEA Pharmaceuticals: Merck KGaA: Solid set of Q4 results; Outlook for 2015 in line with our expectations; Rebif remains key pressure point	Moody's Investors Service
12 Dec 2014	Rating Action	Moody's downgrades Merck KGaA's ratings to Baa1; negative outlook	Moody's Investors Service
01 Dec 2014	Rating Action	Moody's assigns (P)Baa3 to Merck KGaA's new hybrid notes	Moody's Investors Service
17 Nov 2014	Announcement	Moody's: Focus of European M&A shifts to US companies	Moody's Investors Service
25 Sep 2014	Issuer Comment	Merck's Offer for Sigma-Aldrich Is Credit Negative	Moody's Investors Service
24 Sep 2014	Credit Focus	Merck KGaA: Frequently Asked Questions About its Offer to Acquire Sigma-Aldrich Corporation	Moody's Investors Service
23 Sep 2014	Rating Action	Moody's places A3 ratings of Merck KGaA on review for downgrade	Moody's Investors Service
08 Jul 2014	Company Profile	Merck KGaA	Moody's Investors Service
12 Jun 2014	Announcement	Moody's: New Cancer Drugs Create Big Opportunities in Pharmaceutical Industry	Moody's Investors Service
05 Dec 2013	Issuer Comment	Moody's : Merck KGaA's A3 rating unchanged following bid for AZ Electronic Materials	Moody's Investors Service
05 Jul 2013	Credit Focus	Merck KGaA: Frequently Asked Questions	Moody's Investors Service
04 Jul 2013	Rating Action	Moody's upgrades Merck KGaA to A3; stable outlook	Moody's Investors Service
03 Jun 2013	Company Profile	Merck KGaA	Moody's Investors Service
23 May 2013	Issuer Comment	Merck KGaA's sale of its Geneva site is credit positive	Moody's Investors Service
19 Dec 2012	Rating Action	Moody's upgrades Merck KGaA to Baa1; stable outlook	Moody's Investors Service
26 Jun 2012	Announcement	Moody's changes outlook on Merck KGaA's Baa2 ratings to positive	Moody's Investors Service

Results 1 - 50 Of 84

Page Of 2 Next

Research & Ratings

Products & Solutions

News & Events

Registered User

Not Registered Yet?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: